1. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes;Chang;Cancer Res,1993
2. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines;Chang;Cancer Res,1997
3. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles;Roy;Drug Metab Dispos,1999
4. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide;Huang;Biochem Pharmacol,2000
5. An overview of cyclophosphamide and ifosfamide pharmacology;Fleming;Pharmacotherapy,1997